Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032389 · ClinicalTrials.gov registry record · Phase 2
A Polypill for Acute Coronary Syndrome
A Phase 2 study of Acute Coronary Syndrome, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT07032389 is a Phase 2 study of Acute Coronary Syndrome that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,000 participants, below the 2,697-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07032389, a Phase 2 study of Acute Coronary Syndrome, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improve outcomes following an ACS event. Although these therapies are effective, gaps in adherence and uptake significantly contribute to risk or adverse events in the post-ACS period. This study is designed as a pragmatic, multi-center, randomized trial to assess the feasibility and effectiveness of a polypill-based strategy for treatment of ACS.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Polypill
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-12-05 |
| Est. Completion | 2029-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07032389
The ClinicalTrials.gov registry entry for NCT07032389 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,697-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (63% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Polypill is the first listed.
NCT07032389 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07032389 about?
NCT07032389 is a clinical study titled "A Polypill for Acute Coronary Syndrome". The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improve outcomes following an ACS event. Although these therapies are effective, gaps in adherence and upt...
What is the current status of trial NCT07032389?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 1,000 participants. The study started on 2025-12-05. Estimated completion is 2029-08-01.
What conditions does trial NCT07032389 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome.
What interventions are being tested in trial NCT07032389?
The interventions under investigation include: Polypill (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07032389?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07032389 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Online Tai Chi Plus Fitbit After ACS
ACTIVE NOT RECRUITING · Phase 2
-
Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome
COMPLETED · Phase 2
-
Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
COMPLETED · Phase 2
-
A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation
COMPLETED · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.